The Effect of Oral L-arginine Supplementation on Blood Pressure in Patients with Metabolic Syndrome: A Randomized Clinical Trial

Journal Title: Iranian Journal of Diabetes and Obesity - Year 2018, Vol 10, Issue 1

Abstract

Objective: Hypertension is a common component of metabolic syndrome (MetS). Some studies showed that L-arginine reduced the blood pressure (BP) .Therefore this study was designed to evaluate the effect of L-arginine supplementation on BP in MetS. Materials and Methods: In this randomized, double-blind, placebo-controlled trials, 60 patients with MetS were randomly divided into two groups: the L-arginine-supplemented group (AG), who received 5 gr of L-arginine daily and placebo group (PG). Systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), pulse pressure (PP) were measured before and after the intervention and compared. Results: At the end of the study in the AG significant reductions were observed in the SBP, DBP and MAP (P-value:0.001).The comparison of changes in variables between the AG and PG indicated that in the AG, patients had a significantly greater decrease in the SBP (-11.25±10.93 vs. -2.67±6.15 mmHg: P-value:0.001), DBP(-5.71±7.16 vs. -1.25±7.02 mmHg: p-value: 0.02) and MAP (-7.55±5.61 vs.-1.72±5.16 mmHg, P-value: 0.001). The PP decreased in both groups but a significant decrease compared with baseline in the AG was observed (-5.53±13.83 vs. -1.42±9.21 mmHg: P-value: 0.19). Conclusion: The findings of the present study showed that 5 gr/d L- arginine supplementation for 12 weeks in MetS resulted in significant decrease in the SBP, DBP and MAP but had no significant effect on the PP

Authors and Affiliations

Davood Bahrami, Hassan Mozaffari Khosravi

Keywords

Related Articles

Genetics of Type 2 Diabetes- A Review Article

Objective: Type 2 diabetes (T2D) as a complex disease is the result of genetically heterogeneous factors and environmental issues interaction. Linkage and small-scale candidate gene studies were successful in identificat...

Relation between Malnutrition–Inflammation–Atherosclerosis (MIA complex) in Diabetic Patients with Peritoneal Dialysis

Objective: Atherosclerosis disease, inflammation and malnutrition have strong association with end stage renal disease (ESRD). Diabetes mellitus (DM) is the most commonly ESRD causes. Diabetic nephropathy (DN) could be a...

The Effect of Oral L-arginine Supplementation on Blood Pressure in Patients with Metabolic Syndrome: A Randomized Clinical Trial

Objective: Hypertension is a common component of metabolic syndrome (MetS). Some studies showed that L-arginine reduced the blood pressure (BP) .Therefore this study was designed to evaluate the effect of L-arginine supp...

Effect of 12 Weeks Aerobic Training on FOXO1 Gene Expression in Pancreatic Tissue of Type 2 Diabetes Wistar Rats

Objective: Exercise as a non-pharmacological treatment plays an important role in regulating and reducing the inflammatory cytokine associated with beta cell function. Genetics is one of the most important and effective...

Insulin effect on Leptin Concentration in Children with New Onset Insulin Dependent Diabetes Mellitus

Objective: Serum Leptin concentration reflects the body fat mass. There is controversial reports about the insulin effect on serum Leptin concentration. We wanted to examine the effect of insulin therapy on serum Leptin...

Download PDF file
  • EP ID EP636072
  • DOI -
  • Views 49
  • Downloads 0

How To Cite

Davood Bahrami, Hassan Mozaffari Khosravi (2018). The Effect of Oral L-arginine Supplementation on Blood Pressure in Patients with Metabolic Syndrome: A Randomized Clinical Trial. Iranian Journal of Diabetes and Obesity, 10(1), 1-10. https://europub.co.uk/articles/-A-636072